Nierode et al. ANOVA analysis of the individual and combined effects of RA and CHIR on expression of neuronal subtype specific protein markers. Analysis of a dose-response factorial screen of RA, CHIR and combined treatments on expression of pan-neuronal (TUBB3), dopaminergic (TH), GABAergic (GAD65), cholinergic (CHAT) and glutamatergic (VGLUT2) protein markers from two independent screens, wherein each condition had three technical replicates per chip screen (n=6 total replicates per condition and marker). N.S. = non-significant effect. ANOVA from a dose-response.